Vericel (VCEL) Cash from Investing Activities (2010 - 2026)

Vericel (VCEL) reported Cash from Investing Activities of -$4.2 million for Q1 2026, up 72.26% on a YoY basis from -$2.4 million in Q1 2025, and up 74.37% sequentially from -$16.4 million in Q4 2025.

Vericel (VCEL) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Vericel (VCEL) has 17 years of Cash from Investing Activities data on file, last reported at -$4.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities rose 72.26% year-over-year to -$4.2 million; the trailing twelve-month figure through Mar 2026 stood at -$33.0 million (up 51.99% YoY), and the FY2025 full-year result was -$43.9 million, up 44.41% from the prior year.
  • Cash from Investing Activities grew to -$4.2 million in Q1 2026, from -$16.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $4.6 million in Q3 2023 to a low of -$25.5 million in Q1 2024.
  • A 5-year average of -$9.8 million and a median of -$9.0 million in 2025 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities sank 1252.73% in 2022 and soared 663.01% in 2023, its largest moves.
  • Tracing VCEL's Cash from Investing Activities over 5 years: stood at -$21.7 million in 2022, then soared by 62.78% to -$8.1 million in 2023, then slumped by 81.14% to -$14.7 million in 2024, then dropped by 11.87% to -$16.4 million in 2025, then surged by 74.37% to -$4.2 million in 2026.
  • Business Quant data shows VCEL's Cash from Investing Activities at -$4.2 million in Q1 2026, -$16.4 million in Q4 2025, and -$3.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn - -
2 Nanobiotix 1,913.50 Bn 1,913.44 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 473.74 Bn 468.95 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 122.07 Bn 114.82 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 70.00 Bn 61.24 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.34 Bn 62.34 Bn - -
8 Argenx Se 55.96 Bn 50.77 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn -25.54 Mn
10 Vericel 2.33 Bn 2.18 Bn 49.27 Mn -4.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.20 Mn
Mar 31, 2026 -4.20 Mn
Dec 31, 2025 -16.39 Mn
Dec 31, 2025 -16.39 Mn
Sep 30, 2025 -3.38 Mn
Sep 30, 2025 -3.38 Mn
Jun 30, 2025 -9.03 Mn
Jun 30, 2025 -9.03 Mn
Mar 31, 2025 -15.14 Mn
Mar 31, 2025 -15.14 Mn
Dec 31, 2024 -14.65 Mn
Dec 31, 2024 -14.65 Mn
Sep 30, 2024 -21.21 Mn
Sep 30, 2024 -21.21 Mn
Jun 30, 2024 -17.72 Mn
Jun 30, 2024 -17.72 Mn
Mar 31, 2024 -25.45 Mn
Mar 31, 2024 -25.45 Mn
Dec 31, 2023 -8.09 Mn
Dec 31, 2023 -8.09 Mn